AMIODARONE - BENEFITS AND RISKS IN PERSPECTIVE

被引：50

作者：

ROTMENSCH, HH ^{[1
]}

BELHASSEN, B ^{[1
]}

FERGUSON, RK ^{[1
]}

机构：

[1] ICHILOV HOSP,MUNICIPAL GOVT MED CTR,SACKLER SCH MED,DEPT CARDIOL,TEL AVIV,ISRAEL

来源：

AMERICAN HEART JOURNAL | 1982年 / 104卷 / 05期

关键词：

D O I：

10.1016/0002-8703(82)90457-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1117 / 1119

页数：3

相关论文

共 28 条

[1] BELHASSEN B, 1981, 2ND P EUR S CARD PAC
[2] CHARLIER R, 1969, CARDIOLOGIA, V54, P82
[3] CHARLIER R, 1970, J PHARMACOL-PARIS, V1, P175
[4] COUMEL P, 1973, J AGREGES, V6, P69
[5] DISPARITY BETWEEN THE CLINICAL AND ELECTROPHYSIOLOGIC EFFECTS OF AMIODARONE IN THE TREATMENT OF RECURRENT VENTRICULAR TACHYARRHYTHMIAS
HAMER, AW
FINERMAN, WB
PETER, T
MANDEL, WJ
[J]. AMERICAN HEART JOURNAL, 1981, 102 (06) : 992 - 1000
[6] AMIODARONE - CLINICAL EFFICACY AND ELECTROPHYSIOLOGY DURING LONG-TERM THERAPY FOR RECURRENT VENTRICULAR-TACHYCARDIA OR VENTRICULAR-FIBRILLATION
HEGER, JJ
PRYSTOWSKY, EN
JACKMAN, WM
NACCARELLI, GV
WARFEL, KA
RINKENBERGER, RL
ZIPES, DP
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (10) : 539 - 545
[7] LONG-TERM MANAGEMENT OF SUSTAINED, RECURRENT, SYMPTOMATIC VENTRICULAR-TACHYCARDIA WITH AMIODARONE
KASKI, JC
GIROTTI, LA
MESSUTI, H
RUTITZKY, B
ROSENBAUM, MB
[J]. CIRCULATION, 1981, 64 (02) : 273 - 279
[8] KIM SG, 1982, PACE, V5, P305
[9] CONTROL OF REFRACTORY CARDIAC-ARRHYTHMIAS WITH AMIODARONE
LEAK, D
EYDT, JN
[J]. ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (04) : 425 - 428
[10] CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS OF THE ANTI-ARRHYTHMIC AGENT, AMIODARONE
MARCUS, FI
FONTAINE, GH
FRANK, R
GROSGOGEAT, Y
[J]. AMERICAN HEART JOURNAL, 1981, 101 (04) : 480 - 493